South Korean pharmaceutical company Yuhan Yanghang celebrated its 100th anniversary, reaffirming its commitment to becoming a global innovator in the pharmaceutical industry. CEO Cho Wook-jae announced the company’s intention to prioritize research and development to contribute to human health worldwide. The celebration highlighted Yuhan Yanghang’s historical contributions to the South Korean pharmaceutical sector and its future ambitions. The company plans to accelerate its development of novel therapeutics and expand its international presence. This milestone signifies a renewed dedication to innovation and a commitment to addressing unmet medical needs globally. Yuhan Yanghang aims to build upon its legacy as a leading pharmaceutical firm in Korea and establish itself as a significant player on the international stage. The anniversary event underscored the company’s long-term vision for sustainable growth and positive societal impact.